Información del artÃculo
El Texto completo está disponible en PDF
bibliografía
[1.]
M.E. Pichichero, J.R. Casey, T. Mayes, A.B. Francis, S.M. Marsocci, A.M. Murphy, et al.
Penicillin failure in streptococcal tonsillopharyngitis: causes and remedies.
Pediatr Infect Dis J, 19 (2000), pp. 917-923
[2.]
J. Tsevant, U.R. Kotagal.
Management of sore throats in children. A cost-effectiveness analysis.
Arch Pediatr Adolesc Med, 153 (1999), pp. 681-688
[3.]
C. Contessoto, M.S. Camara, M.J. Aviles, J.M. Ojeda, I. Cascales, F. Rodriguez-Sanchez.
Empleo racional de antibioticos en pediatria: impacto de la aplicacion de un test rapido de deteccion de estreptococo beta-hemolitico del grupo A en la faringoamigdalitis aguda.
An Esp Ped, 52 (2000), pp. 212-219
[4.]
S.T. Shulman, R.R. Tanz, M.A. Gerber.
Streptococcal pharyngitis.
Streptococcal Infections. Clinical aspects, microbiology and molecular pathogenesis, pp. 76-101
[5.]
A. Dajani, K. Taubert, P. Ferrieri, G. Peter, S. Shulman.
Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals.
Pediatrics, 96 (1995), pp. 758-764
[6.]
M. Markowitz, M.A. Gerber, E.L. Kaplan.
Treatment of streptococcal pharyngotonsillitis: reports of penicillin's demise are premature.
J Pediatr, 123 (1993), pp. 679-685
[7.]
A.L. Bisno, M.A. Gerber, J.M. Gwaltney, E.L. Kaplan, R.H. Schwartz.
Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis.
Clin Infect Dis, 35 (2002), pp. 113-125
[8.]
American Academy of Pediatrics.
Group A streptococcal infections.
Red Book 2003 Report of the Committe on Infectious Diseases, 26th ed, pp. 573-584
[9.]
M.A. Gerber, M.F. Randolph, J. Chanatry, L.L. Wright, K. De Meo, E.L. Kaplan.
Five vs. ten days of penicillin V therapy for streptococcal pharyngitis.
Am J Dis Child, 141 (1987), pp. 224-227
[10.]
C. Olivier.
Rheumatic fever.
Is it still a problem? J Antimicrob Chemother, 45 (2000), pp. 13-21
[11.]
B. Schwartz, S.M. Marcy, W.R. Phillips, M.A. Gerber, S.F. Dowell.
Pharyngitis. Principles of judicious use of antimicrobial agents.
Pediatrics, 101 (1998), pp. 171-174
[12.]
M.E. Pichichero, P.A. Margolis.
A comparison of cephalosporins and penicillins in the treatment of group A beta-hemolytic streptococcal tonsilopharyngitis.
Pediatr Infect Dis J, 10 (1991), pp. 275-281
[13.]
E.L. Kaplan, D.R. Johnson.
Unexplained reduced microbiological efficacy of intramuscular benzatine penicillin G and of oral penicillin V in eradication of group A streptococci from children with acute pharyngitis.
Pediatrics, 108 (2001), pp. 1180-1186
[14.]
L. Pacifico, F. Scopetti, A. Ranucci, M. Pataracchia, F. Savignoni, C. Chisea.
Comparative efficacy and safety of 3-day azithromycin and 10-day penicillin V treatment of group A beta-hemolytic streptococcal pharyngitis in children.
Antimicrob Agents Chemother, 40 (1996), pp. 1005-1008
[15.]
J. Hamill.
Multicentre evaluation of azithromycin and penicillin V in the treatment of acute streptococcal pharyngitis and tonsillitis in children.
J Antimicrob Chemother, 10 (1993), pp. 89-94
[16.]
M.A. Gerber, M.F. Randolph, K. De Meo, H.M. Feder, E.L. Kaplan.
Failure of once-daily penicillin V therapy for streptococcal pharyngitis.
Am J Dis Child, 143 (1989), pp. 153-155
[17.]
M.S. Krober, M.R. Weir, N.J. Themelis, J.E. Van Hamont.
Optimal dosing interval for penicillin treatment of streptococcal pharyngitis.
Clin Pediatr, 29 (1990), pp. 646-648
[18.]
A. Gené, A. González-Cuevas, C. Muñoz, C. Luaces, C. Latorre.
Actualización de la sensibilidad antibiotica de Streptococcus pyogenes en pediatria.
Enferm Infecc Microbiol Clin, 18 (2000), pp. 143-145
[19.]
S.T. Shulman, M.A. Gerber, R.R. Tanz, M. Markowitz.
Streptococcal pharyngitis. The case for penicillin therapy.
Pediatr Infect Dis J, 13 (1994), pp. 1-7
[20.]
P. Ovetchkine, C. Levy, F. De la Rocque, M. Boucherat, E. Bingen, R. Cohen.
Variables influencing bacteriological outcome in patients with streptococcal tonsillopharyngitis treated with penicillin V.
Eur J Pediatr, 161 (2002), pp. 365-367
[21.]
W.M. Gooh, S.E. McLinn, G.H. Aronovitz, M.E. Pichichero, A. Kumar, E.L. Kaplan, et al.
Efficacy of cefuroxime axetil suspension compared with that of penicillin V suspension in children with group A streptococcal pharyngitis.
Antimicrob Agents Chemother, 37 (1993), pp. 159-163
[22.]
Y. Aujard, I. Boucot, N. Brahimi, D. Chiche, E. Bingen.
Comparative efficacy and safety of four-day cefuroxime axetil and ten-day penicillin treatment of group A beta-hemolytic streptococcal pharyngitis in children.
Pediatr Infect Dis J, 14 (1995), pp. 295-300
[23.]
M.A. Gerber, R.R. Tanz, W. Kabat, G.L. Bell, P.N. Siddiqui, T.J. Lerer, et al.
Potential mechanisms for failure to eradicate group A streptococci from the pharinx.
Pediatrics, 104 (1999), pp. 911-917
[24.]
R.R. Tanz, S.T. Shulman, P.A. Sroka, S. Marubio, I. Brook, R. Yogev.
Lack of influence of betalactamase-producing flora on recovery of group A streptpcocci after treatment of acute pharyngitis.
J Pediatr, 117 (1990), pp. 859-863
[25.]
R. Cohen, C. Levy, C. Doit, F. De la Rocque, M. Boucherat, F. Fitoussi, et al.
Six-day amoxicillin vs. ten-day penicillin V therapy for group A streptococcal tonsillopharyngitis.
Pediatr Infect Dis J, 15 (1996), pp. 678-682
[26.]
J.r. Feder HM, H.A. Gerber, M.F. Randolph, P.S. Stelmach, E.L. Kaplan.
Once-daily therapy for streptococcal pharyngitis with amoxicillin.
Pediatrics, 103 (1999), pp. 47-51
[27.]
D. Adam, H. Scholtz, M. Helmerking.
Short-course antibiotic treatment of 4782 culture- proven cases of group A streptococcal tonsillopharyngitis and incidence of poststreptococcal sequelae.
J Infect Dis, 182 (2000), pp. 509-516
[28.]
U.B. Schaad, P. Kellerhals, M. Altwegg, Group Swiss Pharyngitis Study.
Azithromycin vs. penicillin V for treatment of acute group A streptococcal pharyngitis.
Pediatr Infect Dis J, 21 (2002), pp. 304-308
[29.]
R. Cohen, P. Reinert, F. De la Rocque, C. Levy, M. Boucherat, M. Robert, et al.
Comparison of two dosages of azithromycin for three days vs. penicillin V for ten days in acute group A streptococcal tonsillopharyngitis.
Pediatr Infect Dis J, (2002), pp. 297-303
[30.]
R. Musumeci, C.L. Bue, I. Milazzo, G. Nicoletti, A. Serra, A. Speciale, et al.
Internalization- associated proteins among Streptococcus pyogenes isolated from asymptomatic carriers and children with pharyngitis.
Clin Infect Dis, 37 (2003), pp. 173-179
[31.]
M.E. Pichichero, J.R. Casey.
Defining and dealing with carriers of group A streptococci.
Contemp Pediatr, 1 (2003), pp. 46
[32.]
J. Conley, M.E. Olson, L.S. Cook, H. Ceri, V. Phan, H.D. Davies.
Biofilm formation by group A streptococci: is there a relationship with treatment failure?.
J Clin Microbiol, 41 (2003), pp. 4043-4048
[33.]
M.F. Randolph, M.A. Gerber, K.K. DeMeo, L. Wright.
Effect of antimicrobial therapy on the clinical course of streptococcal pharyngitis.
J Pediatr, 106 (1985), pp. 870-875
[34.]
M.H. Macris, N. Hartman, M. Murray, R.F. Klein, R.B. Roberts, L.E. Kaplan, et al.
Studies of the continuing susceptibility of group A streptococcal strains to penicillin during eight decades.
Pediatr Infect Dis Child J, 17 (1998), pp. 377-381
[35.]
R. Cantón, E. Loza, M.I. Morosini, F. Baquero.
Antimicrobial resistance amongst isolates of Streptococcus Pyogenes and Staphylococcus aureus in the PROTEKT antimicrobial surveillance programme during 1999-2000.
J Antimicrob Chemother, 50 (2002), pp. 9-24
[36.]
A.J. Lan, J.M. Colford.
The impact of dosing frecuency on the efficacy of 10-day penicillin or amoxicillin therapy for streptococcal tonsillopharyngitis: a meta-analysis.
Pediatrics, 105 (2000), pp. 19e
[37.]
A. Kaufhold.
Randomized evaluation of benzathine penicillin V twice daily vs. potassium penicillin three times daily in the treatment of group A streptococcal pharyngitis.
Eur J Clin Microbiol Infect Dis, 14 (1995), pp. 92-98
Copyright © 2004. Elsevier España, S.L.. Todos los derechos reservados